73 results
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
, including safety surveillance, anti-fraud and abuse laws and implementation of corporate compliance programs and reporting of payments or other transfers … Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil FCA. Many states also have similar fraud and abuse
10-K
2023 FY
EX-10.30
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
”), resulting from, based on, or arising out of Third Party claims arising from: (i) the alleged or actual negligence, fraud or wilful misconduct of ReproNovo … with respect to any Losses for which Mereo is required to indemnify the ReproNovo Indemnitees under Section 8.2 or which are the result of any fraud or wilful
10-K
2023 FY
EX-31.2
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
; and
Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over
10-K
2023 FY
EX-31.1
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
; and
Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control
F-3/A
znm8 szujvl
27 Sep 21
Shelf registration (foreign) (amended)
4:18pm
F-3/A
s9eugi qpbz88jbxqqo
7 Sep 21
Shelf registration (foreign) (amended)
4:06pm
F-3
s0voj9m1whpf2
5 Aug 21
Shelf registration (foreign)
4:33pm